Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Digitalisation of Biomanufacturing of Plasmids for the Development of Advanced Therapy Modalities

Project description

Digitalised biomanufacturing for next-generation therapies

Production of biopharmaceuticals and advanced therapies such as mRNA vaccines and gene therapies depends on complex manufacturing processes. These are increasingly difficult to optimise without digital tools. Digitalisation provides the potential to improve efficiency, reduce costs, and ensure quality control. The aim of the EU-funded DIG4BIO project is to advance the digitalisation of biomanufacturing processes through a strategic alliance between research institutions in Denmark, Germany, and Portugal. A particular focus is placed on the bacterial production of plasmid DNA, a key raw material for gene and cell therapies. Through joint research, training, and knowledge exchange, the project will build institutional capacity in digital biotechnology and contribute to next-generation biomanufacturing.

Objective

Digitalization of biDigitalisation of biomanufacturing is key to increasing efficiency, reducing costs, and ensuring quality control in the production of biopharmaceuticals and advanced therapies. Dig4Bio aims to: i) advance the research capacity and profile of the coordinator IST (PT) in the field of digitalisation of biomanufacturing, and ii) strengthen the research management and administrative skills of IST. This will be achieved through a strategic alliance with experts in digital biotechnology from PROSYS, DTU (Chemical and Biochemical Engineering, DK) and lab automation TU Berlin (Chair of Bioprocess Engineering DE). Dig4Bio includes 6 Work Packages (WPs). WP1 (Advancing scientific capacity) and WP2 (Enhancing research management capacity) focus on stepping up the scientific and research management skills of IST through tailored training (workshops, training schools, digital tools, short term visits). In WP3 (Joint research activities), Dig4Bio partners will collaborate on a pioneering R&I initiative that addresses the question: How to develop and incorporate a digitalisation framework in the conceptual design, research and development of biomanufacturing processes. Attention is focused on Escherichia coli-based manufacturing of plasmid DNA, a biomolecule that is gaining increased relevance as a biological (e.g. DNA vaccination, in vivo gene therapy), and as a raw material in the manufacturing of gene/cell therapies (e.g. mRNA vaccines). WP4 (Clustering Activities) aims to foster close ties, synergies and knowledge exchange between the consortium and stakeholders, whereas WP5 (Communication and Dissemination) aims to disseminate findings and promote awareness of the field. WP6 (Coordination and Management) provides the necessary administrative support to ensure the successful and timely execution of all project components. The expected outcomes for Dig4Bio include the elevation of IST profile in digitalisation of biomanufacturing and in research management.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-WIDERA-2023-ACCESS-02

See all projects funded under this call

Coordinator

INSTITUTO SUPERIOR TECNICO
Net EU contribution
€ 459 312,50
Address
AVENIDA ROVISCO PAIS 1
1049 001 Lisboa
Portugal
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (3)